Skip to main content
. Author manuscript; available in PMC: 2011 Jul 5.
Published in final edited form as: Vaccine. 2010 May 14;28(30):4777–4785. doi: 10.1016/j.vaccine.2010.04.099

Figure 3.

Figure 3

Post-infection detection of passively administered anti-Stx2 antibody or Stx2 produced by the infecting wild-type E. coli O157:H7 strain 86-24. The group of mice given NRS is depicted by black bars and the animals administered anti-Stx2 are represented by gray bars. (A) Percentage of mice (n=8) from the NRS and anti-Stx2 administration group with detectable anti-Stx2 antibody shed into the feces after E. coli O157:H7 infection. No detectable anti-Stx2 antibody was seen in the feces of mice administered NRS. (B) Percentage of mice (n=8) from the NRS and anti-Stx2 administration group that shed detectable levels of Stx2 into the feces post-infection.